Javier Rangel-Moreno
Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Lymphoid Tissue | 11 | 2004 | 34 |
Why?
| Chemokine CXCL13 | 7 | 2004 | 4 |
Why?
| Bronchi | 6 | 2004 | 45 |
Why?
| Tuberculosis, Pulmonary | 5 | 2000 | 21 |
Why?
| Chemokines, CXC | 4 | 2004 | 32 |
Why?
| Chemokines, CC | 3 | 2004 | 15 |
Why?
| B-Lymphocytes | 4 | 2005 | 134 |
Why?
| CD4-Positive T-Lymphocytes | 6 | 2003 | 113 |
Why?
| Lung | 6 | 2000 | 233 |
Why?
| Mice | 22 | 2000 | 623 |
Why?
| Influenza, Human | 5 | 2005 | 94 |
Why?
| Interleukin-17 | 4 | 2007 | 11 |
Why?
| Lymphatic System | 1 | 2009 | 12 |
Why?
| Omentum | 1 | 2009 | 12 |
Why?
| Nasal Mucosa | 2 | 2005 | 22 |
Why?
| Mice, Inbred C57BL | 13 | 2003 | 318 |
Why?
| Orthomyxoviridae | 3 | 2004 | 34 |
Why?
| Lung Diseases, Interstitial | 1 | 2006 | 12 |
Why?
| Mycobacterium tuberculosis | 6 | 1999 | 18 |
Why?
| Influenza A virus | 2 | 2003 | 63 |
Why?
| Mice, Knockout | 9 | 2003 | 265 |
Why?
| Arthritis, Rheumatoid | 1 | 2006 | 53 |
Why?
| Animals | 22 | 2000 | 1032 |
Why?
| Chemokine CCL21 | 4 | 2004 | 1 |
Why?
| Chemokine CCL19 | 3 | 2005 | 1 |
Why?
| CD8-Positive T-Lymphocytes | 4 | 2005 | 91 |
Why?
| Cytokines | 6 | 2000 | 207 |
Why?
| Enzyme-Linked Immunosorbent Assay | 6 | 2000 | 224 |
Why?
| Androstenediol | 1 | 2000 | 5 |
Why?
| Lymphotoxin-alpha | 3 | 2005 | 11 |
Why?
| Dinoprostone | 1 | 2002 | 55 |
Why?
| Tularemia | 2 | 2009 | 4 |
Why?
| T-Lymphocytes, Helper-Inducer | 2 | 2010 | 38 |
Why?
| Immunotherapy | 1 | 2000 | 49 |
Why?
| Interleukin-23 | 2 | 2007 | 1 |
Why?
| Mice, Transgenic | 6 | 2003 | 209 |
Why?
| Tuberculosis | 2 | 2007 | 24 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2000 | 243 |
Why?
| Orthomyxoviridae Infections | 3 | 2004 | 29 |
Why?
| Immunologic Memory | 2 | 2006 | 51 |
Why?
| Immunohistochemistry | 4 | 2004 | 356 |
Why?
| Antibodies, Viral | 3 | 2005 | 104 |
Why?
| Granuloma | 2 | 2009 | 38 |
Why?
| Gene Expression | 3 | 2002 | 291 |
Why?
| Th1 Cells | 2 | 2009 | 33 |
Why?
| Immunotherapy, Active | 2 | 2000 | 4 |
Why?
| Hypersensitivity, Delayed | 2 | 2000 | 35 |
Why?
| Antigens, Bacterial | 3 | 1999 | 44 |
Why?
| Disease Models, Animal | 3 | 2009 | 349 |
Why?
| Mice, Inbred BALB C | 3 | 2000 | 176 |
Why?
| BCG Vaccine | 1 | 2010 | 22 |
Why?
| Lymphocyte Activation | 2 | 2003 | 137 |
Why?
| Cytotoxicity, Immunologic | 1 | 2010 | 54 |
Why?
| Bacterial Vaccines | 1 | 2010 | 27 |
Why?
| Francisella tularensis | 1 | 2009 | 3 |
Why?
| Lymph Nodes | 2 | 2008 | 106 |
Why?
| Tumor Suppressor Proteins | 1 | 2010 | 51 |
Why?
| Peritoneum | 1 | 2009 | 14 |
Why?
| T-Lymphocytes, Cytotoxic | 1 | 2010 | 52 |
Why?
| Pneumonia | 1 | 2011 | 85 |
Why?
| Antigens | 1 | 2009 | 66 |
Why?
| Homeostasis | 1 | 2009 | 99 |
Why?
| Immunity, Cellular | 2 | 2004 | 85 |
Why?
| Peyer's Patches | 1 | 2008 | 7 |
Why?
| Immunity, Mucosal | 1 | 2008 | 16 |
Why?
| Repressor Proteins | 1 | 2010 | 96 |
Why?
| Capsid Proteins | 1 | 2008 | 19 |
Why?
| Fluorescent Antibody Technique, Indirect | 1 | 2007 | 36 |
Why?
| Tuberculosis Vaccines | 1 | 2007 | 2 |
Why?
| Antigens, CD40 | 2 | 2003 | 24 |
Why?
| Immune System | 1 | 2008 | 43 |
Why?
| Cell Aggregation | 1 | 2006 | 25 |
Why?
| Adjuvants, Immunologic | 2 | 2004 | 73 |
Why?
| Sjogren's Syndrome | 1 | 2006 | 13 |
Why?
| Mice, Inbred Strains | 1 | 2007 | 118 |
Why?
| Autoantibodies | 1 | 2006 | 65 |
Why?
| Endothelium, Lymphatic | 1 | 2005 | 4 |
Why?
| Chemokines | 1 | 2006 | 48 |
Why?
| Stromal Cells | 1 | 2005 | 41 |
Why?
| Signal Transduction | 3 | 2008 | 313 |
Why?
| Transfer Factor | 1 | 2004 | 1 |
Why?
| Endothelial Cells | 1 | 2006 | 80 |
Why?
| T-Lymphocytes | 1 | 2007 | 182 |
Why?
| Male | 5 | 2000 | 1558 |
Why?
| B-Lymphocyte Subsets | 1 | 2003 | 33 |
Why?
| CD40 Ligand | 1 | 2003 | 51 |
Why?
| RNA, Messenger | 2 | 2006 | 394 |
Why?
| Immunity, Innate | 3 | 2005 | 60 |
Why?
| Niflumic Acid | 1 | 2002 | 3 |
Why?
| Cyclooxygenase 1 | 1 | 2002 | 41 |
Why?
| Cyclooxygenase 2 Inhibitors | 1 | 2002 | 45 |
Why?
| Cyclooxygenase Inhibitors | 1 | 2002 | 47 |
Why?
| Bacterial Proteins | 2 | 1999 | 99 |
Why?
| Cyclooxygenase 2 | 1 | 2002 | 77 |
Why?
| Prostaglandin-Endoperoxide Synthases | 1 | 2002 | 66 |
Why?
| Colony Count, Microbial | 1 | 2000 | 45 |
Why?
| Disease Progression | 1 | 2002 | 244 |
Why?
| Isoenzymes | 1 | 2002 | 144 |
Why?
| Adoptive Transfer | 2 | 2007 | 16 |
Why?
| Humans | 6 | 1999 | 1858 |
Why?
| Antigen Presentation | 2 | 2007 | 28 |
Why?
| Interferon-gamma | 2 | 2009 | 133 |
Why?
| Ovalbumin | 2 | 2003 | 32 |
Why?
| Membrane Proteins | 1 | 2002 | 233 |
Why?
| Lymphocytes | 2 | 2004 | 142 |
Why?
| Inflammation | 2 | 2008 | 208 |
Why?
| Female | 3 | 2006 | 1646 |
Why?
| Aged | 1 | 2006 | 992 |
Why?
| Flow Cytometry | 2 | 2004 | 216 |
Why?
| Time Factors | 2 | 2009 | 896 |
Why?
| Tumor Necrosis Factor-alpha | 2 | 2004 | 210 |
Why?
| Middle Aged | 1 | 2006 | 1166 |
Why?
| Adult | 1 | 2006 | 1321 |
Why?
| Neutrophil Infiltration | 1 | 2011 | 17 |
Why?
| Granzymes | 1 | 2010 | 3 |
Why?
| Interleukin-23 Subunit p19 | 1 | 2010 | 1 |
Why?
| ZAP-70 Protein-Tyrosine Kinase | 1 | 2010 | 6 |
Why?
| Pore Forming Cytotoxic Proteins | 1 | 2010 | 6 |
Why?
| Listeria monocytogenes | 1 | 2010 | 6 |
Why?
| Listeriosis | 1 | 2010 | 4 |
Why?
| Antigens, CD8 | 1 | 2010 | 25 |
Why?
| Immunity | 1 | 2011 | 46 |
Why?
| Chemokine CXCL2 | 1 | 2010 | 29 |
Why?
| Phospholipase C gamma | 1 | 2010 | 17 |
Why?
| Antibody-Producing Cells | 1 | 2010 | 20 |
Why?
| Granulocytes | 1 | 2010 | 46 |
Why?
| Clone Cells | 1 | 2010 | 92 |
Why?
| Receptors, Antigen, T-Cell | 1 | 2010 | 34 |
Why?
| Enhancer Elements, Genetic | 1 | 2010 | 43 |
Why?
| Macrophage Activation | 1 | 2009 | 42 |
Why?
| Cell Count | 1 | 2010 | 163 |
Why?
| T-Lymphocyte Subsets | 1 | 2010 | 70 |
Why?
| Receptors, Cell Surface | 1 | 2010 | 115 |
Why?
| Peptide Fragments | 1 | 2010 | 145 |
Why?
| Dendritic Cells | 1 | 2009 | 60 |
Why?
| Neutrophils | 1 | 2010 | 114 |
Why?
| Vaccination | 1 | 2010 | 92 |
Why?
| Gene Expression Profiling | 1 | 2011 | 138 |
Why?
| Cell Movement | 1 | 2010 | 163 |
Why?
| Autoimmunity | 1 | 2008 | 27 |
Why?
| Interleukin-6 | 1 | 2010 | 146 |
Why?
| Organ Specificity | 1 | 2008 | 104 |
Why?
| Nasal Cavity | 1 | 2007 | 12 |
Why?
| Protein Binding | 1 | 2010 | 256 |
Why?
| Disease Susceptibility | 1 | 2007 | 61 |
Why?
| Immunologic Deficiency Syndromes | 1 | 2007 | 30 |
Why?
| Models, Immunological | 1 | 2007 | 40 |
Why?
| Mice, Mutant Strains | 1 | 2007 | 77 |
Why?
| Cell Proliferation | 1 | 2010 | 227 |
Why?
| Genes, T-Cell Receptor delta | 1 | 2005 | 1 |
Why?
| Genes, T-Cell Receptor beta | 1 | 2005 | 6 |
Why?
| Immunoglobulin Class Switching | 1 | 2005 | 17 |
Why?
| Antibodies, Monoclonal | 1 | 2010 | 242 |
Why?
| Respiratory Tract Infections | 1 | 2007 | 57 |
Why?
| Chromium Radioisotopes | 1 | 2004 | 7 |
Why?
| Bromodeoxyuridine | 1 | 2004 | 47 |
Why?
| Gene Expression Regulation | 1 | 2010 | 279 |
Why?
| Nitric Oxide Synthase Type II | 1 | 2004 | 39 |
Why?
| Nitrohydroxyiodophenylacetate | 1 | 2003 | 1 |
Why?
| Antitubercular Agents | 1 | 2004 | 5 |
Why?
| Radiation Chimera | 1 | 2003 | 11 |
Why?
| Histocompatibility Antigens Class II | 1 | 2005 | 50 |
Why?
| Fluorescent Antibody Technique | 1 | 2004 | 164 |
Why?
| Apoptosis | 1 | 2010 | 265 |
Why?
| Blotting, Northern | 1 | 2004 | 152 |
Why?
| Sequence Analysis, DNA | 1 | 2004 | 111 |
Why?
| Epitopes, T-Lymphocyte | 1 | 2003 | 17 |
Why?
| Models, Animal | 1 | 2004 | 85 |
Why?
| DNA, Complementary | 1 | 2004 | 139 |
Why?
| Recurrence | 1 | 2005 | 261 |
Why?
| Interleukin-4 | 1 | 2004 | 62 |
Why?
| Nitric Oxide Synthase | 1 | 2004 | 45 |
Why?
| Immunoglobulin G | 1 | 2005 | 192 |
Why?
| Skin | 1 | 2004 | 177 |
Why?
| Bone Marrow Transplantation | 1 | 2003 | 90 |
Why?
| Rats | 1 | 2008 | 532 |
Why?
| Reference Standards | 1 | 1999 | 35 |
Why?
| Cell Differentiation | 1 | 2003 | 262 |
Why?
| Case-Control Studies | 1 | 1999 | 284 |
Why?
|
|
Rangel-Moreno's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
